Nanaz Mohtashami Elected to Hologic Board of Directors
22 Setembro 2023 - 9:00AM
Business Wire
Hologic, Inc. (Nasdaq: HOLX) announced today that Nanaz
Mohtashami has been elected to the Company’s Board of Directors,
effective September 20, 2023. Ms. Mohtashami was also appointed to
the Compensation Committee and the Nominating and Corporate
Governance Committee effective September 20, 2023.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230922633726/en/
(Photo: Business Wire)
Ms. Mohtashami is a Managing Director at Russell Reynolds
Associates, a leading executive search and leadership advisory
firm, where she heads their global Med Tech, Devices &
Diagnostics Practice. Ms. Mohtashami joined Russell Reynolds in
November 2013 and held various roles of increasing responsibility
before becoming a Managing Director in June 2018. Prior to joining
Russell Reynolds, Ms. Mohtashami spent 13 years as a strategy
consultant with Monitor Group, advising leading clients both in the
UK and around the globe.
“It is a pleasure to welcome Nanaz to our Board,” said Steve
MacMillan, Hologic’s Chairman, President and Chief Executive
Officer. “Her exceptional background in both global strategy and
deep experience in the broader healthcare sector, combined with her
strong team orientation, make her yet another strong addition to
our board.”
Ms. Mohtashami holds a BA and M.Eng. from Cambridge University
and a Master of Business Administration from INSEAD.
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company
primarily focused on improving women's health and well-being
through early detection and treatment. For more information on
Hologic, visit www.hologic.com.
Forward Looking Statements
This press release contains forward-looking information that
involves risks and uncertainties, including statements about the
Company's plans, objectives, expectations and intentions, and
statements regarding the Company's Board of Directors. These
forward-looking statements are based on assumptions made by the
Company as of this date and are subject to known and unknown risks
and uncertainties that could cause actual results to differ
materially from those anticipated. These risks include, but are not
limited to, the risk that the Company may not be able to attract
and retain qualified Board members or executives. These risks are
not exhaustive. Other factors that could adversely affect the
Company's business and prospects are described in the filings made
by the Company with the SEC. The Company expressly disclaims any
obligation or undertaking to release publicly any updates or
revisions to any such statements presented here to reflect any
change in expectations or any change in events, conditions or
circumstances on which any such statements are based.
SOURCE: Hologic, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230922633726/en/
Investor Contact: Ryan Simon +1 858.410.8514
ryan.simon@hologic.com
Media Contact: Bridget Perry +1 508.263.8654
bridget.perry@hologic.com
Hologic (NASDAQ:HOLX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Hologic (NASDAQ:HOLX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024